Kolexia
Charbonnier Amandine Hématologie
Charbonnier Amandine
Hématologie
Centre Hospitalier D'Amiens Salouël Site Sud
Salouël, France
108 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Leucémies Leucémie aigüe myéloïde Lymphomes Leucémie myéloïde Maladie de Hodgkin Myélofibrose primitive Tumeurs cutanées Lymphome T

Collaborateurs

Voir plus
Huynh-Finkeltin Anne
Huynh-Finkeltin Anne
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Nguyen-Quoc Stephanie
Nguyen-Quoc Stephanie
Hôpital Pitie Salpetriere, Paris, France
Cornillon Jérôme
Cornillon Jérôme
Institut de Cancérologie de la Loire Lucien Neuwirth, Saint-Priest-en-Jarez, France

Industries

Voir plus
Novartis
5 collaboration(s)
Dernière en 2023
Incyte
2 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2023
AstraZeneca
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
Journal of hematology & oncology   07 janvier 2024
HAPLO-EMPTY: Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression: a Nationwide Phase II Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   21 novembre 2023
FLUCLORIC: Randomized Multicentric Phase III Study Comparing the Efficacy of 2 Reduced Intensity Conditioning Regimens (Clofarabine/Busulfan vs Fludarabine/Busulfan) in Adults With AML and Eligible to Allogeneic Stem Cell Transplantation
Essai Clinique (CHU Nantes)   13 novembre 2023
T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence
65th ASH Annual Meeting Abstracts   02 novembre 2023
Allogeneic Hematopoietic Cell Transplantation in the Elderly Results in Similar Survival with Matched Related or Unrelated and Haploidentical Donors: A Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Checkpoint Inhibitors and Allo-SCT in Hodgkin Lymphoma: A Matter of Time - a Study By the SFGM-TC
65th ASH Annual Meeting Abstracts   02 novembre 2023
Comparison of Two Reduced Intensity Conditioning Regimens (Baltimore with Clofarabine vs Thiotepa-Busulfan-Fludarabine) in Adults Receiving Peripheral Blood Stem Cell Haploidentical Transplantation for Myeloid Malignancies: A Retrospective Study of the SFGM-TC
65th ASH Annual Meeting Abstracts   02 novembre 2023
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study from the Société Francophone De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Interleukin 10 (IL10) and IL15 Significantly Decreased in Chronic Myeloid Leukemia Patients Presenting with Tyrosine Kinase Inhibitor (TKI) Withdrawal Syndrome (TWS). Results from the Prospective, Explorative and Multicenter « Kiwis » Study Designed for TWS. Clinicaltrial.Gov ID: NCT03996096; Study Number: 18-206
65th ASH Annual Meeting Abstracts   02 novembre 2023
Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease : Results from Early Access Program in Europe
65th ASH Annual Meeting Abstracts   02 novembre 2023